ArticlePlastic and reconstructive surgery. Global open2026
Effectiveness of Tranexamic Acid in Postbariatric Surgery Abdominoplasty: Improving Hemostasis and Recovery Outcomes.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and Safety of Tranexamic Acid in Abdominoplasty: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postbariatric abdominoplasty carries an increased risk of perioperative bleeding due to extensive dissection and tissue fragility. Tranexamic acid (TXA) effectively reduces blood loss in several surgical fields, but evidence in postbariatric body-contouring surgery remains limited. Methods: A single-center, retrospective pilot study of 200 postbariatric abdominoplasty patients was conducted. One hundred patients received perioperative TXA (intravenous and local), and 100 historical controls did not. Outcomes measured included hemoglobin drop, 24-hour drain output, complications, and hospital stay. Results: TXA use significantly reduced hemoglobin drop (1.6 ± 0.5 versus 3.1 ± 0.7 g/dL; Conclusions: TXA is associated with reduced blood loss and shorter hospitalization in postbariatric abdominoplasty, without increased thromboembolic risk. TXA should be considered as part of perioperative management for this population.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.